We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Pharmacogenomic Microarray for Clinical Applications

By HospiMedica staff writers
Posted on 10 Jul 2003
A new microarray is designed to enable clinical diagnostic laboratories to identify certain naturally occurring variations, called polymorphisms, in two genes that play a major role in drug metabolism: CYP2D6 and CYP2C19.

These variations affect the rate at which an individual metabolizes drugs used to treat cardiovascular disease, high blood pressure, depression, and other disorders. More...
When considered with other contributing factors, these variations can help doctors select the best drug for a patient and set the right dose sooner while also avoiding drugs that may cause the patient to suffer serious adverse reactions.

Called the AmpliChip CYP 450, the microarray was developed by Roche (Basel, Switzerland) on the microarray platform of Affymetrix (Santa Clara, CA, USA). The CYP450 represents a diagnostic-quality tool that has the potential to address the serious and unpleasant side effects of medication and thereby improve both the success of therapy and the patient's quality of life.

"The launch of the AmpliChip CYP450 microarray represents an important milestone in Roche's development of the individualized medicine market,” said Heino von Prondzynski, head of Roche Diagnostics. Roche will sell the microarray initially as an analyte-specific reagent (ASR) for use by high-complexity laboratories performing CYP2D6 and CYP2C19 genotyping tests.





Related Links:
Roche
Affymetrix

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.